Pathological and clinical characteristics of 1,248 non-Hodgkin's lymphomas from a regional cancer hospital in Shandong, China

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 11, 2011, Pages 3055-3061

  Liu, Jie ^a,b   Song, Bao ^b   Fan, Tingyong ^a,b   Huang, Chengsuo ^b   Xie, Chao ^b   Li, Jing ^b   Zhong, Weixia ^c   Li, Sheng ^a   Yu, Jinming ^b  

^a SHANDONG UNIVERSITY   (China)

^b The Fourth People's Hospital of Jinan city   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

2001 WHO diagnostic criteria; Distribution; Non hodgkin's lymphoma; Retrospective study

Indexed keywords

EID: 84863309315     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Aisenberg AC (1997). Understanding non-Hodgkin's lymphoma. Sci Med, 4, 28-37.
2. Alexander DD, Mink PJ, Adami HO, et al (2007). The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer, 120, 1-39.
3. Anderson JR, Armitage JO, Weisenburger DD (1998). Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-hodgkin's lymphoma classification project.Ann Onco, 9, 717-20.
4. Anonymous (1985). A retrospective histological study of 9,009 cases of malignant lymphoma in China using the NLPCG classification. The Nationwide Lymphoma Pathology Cooperative Group (NLPCG). Jpn J Clin Oncol, 15, 645-51.
5. Anonymous (2000). The world health organization classification of malignant lymphomas in japan: incidence of recently recognized entities. Lymphoma Study Group of Japanese Pathologists. Pathol Int, 50, 696-702.
6. Baris D, Zahm SH (2000). Epidemiology of lymphomas. Curr Opin Oncol, 12, 383-94.
7. Carreon JD, Morton LM, Devesa SS, et al (2008). Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004. Cancer Causes Control, 19, 1171-81.
8. Chen WL, Tsai WC, Chao TY, et al (2010). The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan. Ann Hematol, 89, 553-62.
9. Clarke CA, Glaser SL, Gomez SL, et al (2011). Lymphoid malignancies in US. Asians: incidence rate differences by birthplace and acculturation. Cancer Epidemiol Biomarkers Prev, 20, 1064-77.
10. Cocco P, Kazerouni N, Zahm SH (2000). Cancer mortality and environmental exposure to DDE in the United States. Environ Health Perspect, 108, 1-4.
11. Gross SA, Zhu X, Bao L, et al (2008). A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China. Int J Hematol, 88, 165-73.
12. Groves FD, Linet MS, Travis LB, et al (2000). Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst, 92, 1240-51.
13. HYPERLINK "http://baike.baidu.com/view/2102969.html" http://baike.baidu.com/view/2102969.html
14. Han X, Kilfoy B, Zheng T, et al (2008). Lymphoma survival patterns by WHO subtype in the United States, 1973-2003. Cancer Causes Control, 19, 841-58.
15. Herrinton LJ, Goldoft M, Schwartz SM, et al (1996). The incidence of non-Hodgkin's lymphoma and its histologic subtypes in Asian migrants to the United States and their descendants. Cancer Causes Control, 7, 224-30.
16. Jaffe E, Harris N, Stein H, et al (2001). World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press
17. Lee SS, Cho KJ, Kim CW, et al (1999). Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms. Histopathology, 35, 345-54.
18. Morton LM, Wang SS, Devesa SS, et al (2006). Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood, 107, 265-76.
19. Nogai H, Dörken B, Lenz G (2011). Pathogenesis of non-Hodgkin's lymphoma. J Clin Oncol, 29, 1803-11.
20. Siegel R, Ward E, Brawley O, et al (2011). Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212-36.
21. Sukpanichnant S (2004). Analysis of 1983 cases of malignant lymphoma in Thailand according to the World Health Organization classification. Hum Pathol, 35, 224-30.
22. Van de Schans SA, Issa DE, Visser O, et al (2011). Diverging trends in incidence and mortality, and improved survival of non-Hodgkin's lymphoma, in the Netherlands, 1989-2007. Ann Oncol, (in press).
23. Wang J, Young L, Win W, et al (2005). Distribution and ZAP-70 expression of WHO lymphoma categories in Shanxi, China: a review of 447 cases using a tissue microarray technique. Appl Immunohistochem Mol Morphol, 13, 323-32.
24. Wang JF, Wang YZ, Chen ZW, et al (2006). Prevalence of lymphoma subtypes in Shanxi according to latest WHO classification. Zhonghua Bing Li Xue Za Zhi, 35, 218-23.
25. Wang SS, Slager SL, Brennan P, et al (2007). Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood, 109, 3479-88.
26. Yang K (1993). A histopathologic and immunopathologic study of 209 malignant lymphoma cases from four regions of China: Suzhou, Nanjing, Qingdao and Shenyang. Zhonghua Zhong Liu Za Zhi, 15, 86-90.
27. Yin HF, Li T, Li JX (2003). Retrospective analysis of 304 cases of malignant lymphomas in pathology: study and practice of the WHO classification of lymphoid neoplasms. Zhonghua Yi Xue Za Zhi, 83, 1556-60.
28. Zhou LQ, Sun Y, Tan WY, et al (2006). The clinical and pathological analysis for 1125 cases with non-Hodgkinps lymphoma. Oncology Progress, 14, 391-7.